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Coronary Artery Calcium: The Cup Is 96% Full*
Harvey S. Hecht, MD
New York, New YorkThe MESA (Multiethnic Study of Atherosclerosis)
study was designed to investigate the prevalence and
progression of subclinical atherosclerosis, including
that defined by coronary artery calcium (CAC) scan-
ning, in an asymptomatic, primary prevention popu-
lation (1,2). Along with several other large prospective
studies, it has established CAC as a strong prognos-
ticator of cardiac events, significantly superior and
additive to all risk-factor–based assessments (Fram-
ingham, Prospective Cardiovascular Münster, Euro-
pean Society of Cardiology) (1–4). Remarkably, it has
not yet been recommended by the American College
of Cardiology/American Heart Association guidelines
for screening the intermediate-risk population, for
which the strongest endorsement has been “it may
See page 1175
be reasonable” (5). The persistent criticism has been
the absence of randomized studies demonstrating a
positive effect of CAC on outcomes (6), notwith-
standing a similar absence of outcome data for
risk-factor–based assessments that are routinely
recommended and for all of the cardiology diagnos-
tic modalities.
The relationship of CAC to significant stenoses has
been extensively investigated in symptomatic patients,
and the direct relationship of increasing CAC
with obstructive disease is well-documented, with
a 99% sensitivity for 50% stenosis in symptom-
atic patients referred for angiography (7,8). How-
ever, the relatively low specificity of CAC—
ranging from 23% for CAC 0 to 79% for CAC
100 (7,8)—has been cited as a major shortcom-
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Systems.ing, even though CAC scanning was never in-
tended to detect obstructive disease and get
patients into the catheterization laboratory; the
purpose has always been to detect the early
subclinical stages of the disease for which the
specificity is virtually 100% and keep patients out
of the catheterization laboratory by practicing
aggressive prevention.
The remarkably benign prognosis (0.17%/year
event rate, including revascularization) (Table 1) of
a 0 CAC in the major prospective studies of
asymptomatic patients (2–4) is superior to that of
nuclear stress testing (9) and stress echocardiogra-
phy (10). Nonetheless, the occurrence of
events subsequent to a 0 CAC has been well
documented. Retrospective studies in both older
(114 patients, mean age 57  11 years) (11) and
younger (102 patients, mean age 41  7 years) (12)
populations have yielded a 5% incidence of 0 CAC
in those who presented with acute events in both
age ranges. More recently, the association of 0
calcium scores with significant obstructive disease
has been described in chest pain patients undergo-
ing both computed tomographic angiography
(CTA) and catheter-based angiography (13,14). In
688 patients with chest pain syndromes, 125 pa-
tients had 0 CAC, 7% of which had 50% stenosis
(13). In 40 patients admitted with suspected acute
coronary syndrome, 13 patients had 0 CAC, and 5
of these (39%) had 50% stenosis (14).
The study by Rosen et al. (15) in this issue of
iJACC is the first to prospectively evaluate a very
large asymptomatic cohort of individuals with
known 0 CAC for obstructive disease. Of 6,814
patients enrolled in the MESA study, 3,563 had 0
CAC. In the first 6 years, 175 underwent coronary
angiography after a median interval of 18 months
from the CAC scan, 80% for clinical indications
(angina, myocardial infarction, or congestive heart
failure), 5% as a direct result of the CT study, and
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1185% due to a positive stress test. In 7 patients (4%)
ith 75% stenosis, the CAC was 0; 10% to 20%
f the vessels with 75% stenosis had 0 CAC. Of
he 3,563 with a 0 CAC, only 11 (0.3%) had50%
tenosis on clinically indicated catheter angiogra-
hy. The authors concluded: “. . . the degrees of
oronary artery calcified plaque scores predict the
everity of coronary stenosis of individual coronary
rteries in patients who subsequently require coro-
ary catheterization for clinical indications. Among
hose individuals who underwent coronary angiog-
aphy during this time frame due to clinical indi-
ation and were found to have significant coronary
rtery disease, there is a considerable number of
atients (10–20%) who had a zero calcium score in
he corresponding coronary beds at baseline. Yet,
nly a minority of them (4%) had a total zero
alcium score” (15). This MESA study, by virtue of
ts prospective design in a large cohort, very likely
ffers the truest estimate of the incidence of 0 CAC
bstructive disease, even though only those 0 CAC
atients who underwent clinically indicated coro-
ary angiography were evaluated. The incidence of
bstructive disease would very likely have been
igher if all patients had undergone angiography. It
ust be clearly stated that the 10% to 20% preva-
ence of 0 CAC in arteries with 75% stenosis (15)
s much less clinically relevant and is misleading,
ecause it was concentrated in only 4% of the
atients.
All the same, the 96% negative predictive value in
atients presenting with chest pain implies that a 0
AC does not provide sufficient reassurance.
herefore, CAC scanning is not an appropriate tool
or chest pain evaluation. A prior or recent 0 CAC
n a symptomatic patient must be followed by
dditional testing to rule out coronary artery disease
ith significant stenoses.
It is critical that the results not be misinterpreted
s a shortcoming of CAC by extrapolating them to
he entire cohort of asymptomatic patients, as the
Table 1. Prospective Prognostic Studies That Have Assessed the
Study (Ref. #)
Total
Patients, n
0 CAC
Patients, n
Detrano et al. (2) 6,722 3,409
Arad et al. (3) 5,585 1,504
Becker et al. (4) 1,726 379
Pooled data 14,303 5,282
CAC  coronary artery calcium; MI  myocardial infarction.itle “Relationship Between Baseline Coronary Cal- hium Score and Demonstration of Coronary Artery
tenoses During Follow-Up: MESA (Multi-
thnic Study of Atherosclerosis)” (15) would sug-
est. The very low incidence (0.3%) of clinically
ndicated catheter angiography in 3,563 0 CAC
symptomatic patients in the MESA study and the
ow (4%) occurrence of significant obstruction in
he selected symptomatic 0 CAC group (15), al-
ost identical to the 5% previously reported in
atients presenting with an acute event (13,14),
ust be emphasized to hasten rather than further
elay the acceptance of CAC scanning.
A strong argument can be made for requiring
AC before stress testing in asymptomatic pa-
ients, for whom the Class IIb indication for eval-
ation of patients with multiple risk factors (16) is
ommonly applied. A 0 CAC would obviate the
eed for stress testing, which is associated with a
oor positive predictive accuracy in a low-
revalence asymptomatic population, as well as the
voidable normal coronary angiography and atten-
ant costs, morbidity, and mortality. In addition,
ess aggressive drug therapy would be appropriate
or 0 CAC patients. In the current cost-conscious,
vidence-based environment, the burden of proof
hould be on those who choose to use lipid-
owering medications in this remarkably low-risk
roup; demonstration that drug therapy in the 0
AC group significantly reduces events below
.17%/year in a randomized trial should be re-
uired. At the other end of the spectrum, CAC
dentifies the higher risk pool of patients out of
hich 95% to 96% of the events will emerge; it is
his group that will benefit from highly targeted
ggressive treatment. As Rosen et al. (15) have
emonstrated, “the CAC cup is 96% full.”
eprint requests and correspondence: Dr. Harvey S.
echt, Lenox Hill Heart and Vascular Institute, 130 East
7th Street, New York, New York 10021. E-mail:
gnostic Value of a 0 Coronary Calcium Score
Follow-Up,
yrs
MI  Death,
%/yr (n)
All Events,
%/yr (n)
3.9 median 0.06% (8) 0.11% (15)
4.3 mean Not available 0.13% (8)
3.4 mean 0% (0) 0.9% (12)
3.9 Not available 0.17% (35)Prohecht@aol.com.
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